Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2026-02-27 @ 4:35 AM
Study NCT ID:
NCT02685033
Status:
COMPLETED
Last Update Posted:
2019-01-04
First Post:
2016-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
Sponsor:
Durata Therapeutics Inc., an affiliate of Allergan plc
Organization: